GRIFOLS SA-ADR (GRFS)
US3984384087 - ADR
Taking everything into account, GRFS scores 5 out of 10 in our fundamental rating. GRFS was compared to 561 industry peers in the Biotechnology industry. GRFS scores excellent on profitability, but there are concerns on its financial health. GRFS scores decently on growth, while it is valued quite cheap. This could make an interesting combination.
1. Profitability
1.1 Basic Checks
In the past year GRFS was profitable.
In the past year GRFS had a positive cash flow from operations.
Each year in the past 5 years GRFS has been profitable.
Of the past 5 years GRFS 4 years had a positive operating cash flow.
1.2 Ratios
The Return On Assets of GRFS (0.71%) is better than 92.97% of its industry peers.
The Return On Equity of GRFS (2.69%) is better than 93.87% of its industry peers.
Looking at the Return On Invested Capital, with a value of 4.34%, GRFS belongs to the top of the industry, outperforming 94.41% of the companies in the same industry.
GRFS had an Average Return On Invested Capital over the past 3 years of 2.86%. This is significantly below the industry average of 13.83%.
The 3 year average ROIC (2.86%) for GRFS is below the current ROIC(4.34%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.71% | ||
| ROE | 2.69% | ||
| ROIC | 4.34% |
ROA(3y)0.74%
ROA(5y)2.06%
ROE(3y)2.61%
ROE(5y)6.58%
ROIC(3y)2.86%
ROIC(5y)4.04%
1.3 Margins
With an excellent Profit Margin value of 2.05%, GRFS belongs to the best of the industry, outperforming 93.51% of the companies in the same industry.
GRFS's Profit Margin has declined in the last couple of years.
Looking at the Operating Margin, with a value of 14.26%, GRFS belongs to the top of the industry, outperforming 95.68% of the companies in the same industry.
In the last couple of years the Operating Margin of GRFS has declined.
GRFS's Gross Margin of 38.79% is fine compared to the rest of the industry. GRFS outperforms 76.22% of its industry peers.
In the last couple of years the Gross Margin of GRFS has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 14.26% | ||
| PM (TTM) | 2.05% | ||
| GM | 38.79% |
OM growth 3Y-15.14%
OM growth 5Y-12.82%
PM growth 3Y-57.33%
PM growth 5Y-41.65%
GM growth 3Y-3.59%
GM growth 5Y-3.69%
2. Health
2.1 Basic Checks
GRFS has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for GRFS remains at a similar level compared to 1 year ago.
Compared to 5 years ago, GRFS has about the same amount of shares outstanding.
GRFS has a worse debt/assets ratio than last year.
2.2 Solvency
GRFS has an Altman-Z score of 1.17. This is a bad value and indicates that GRFS is not financially healthy and even has some risk of bankruptcy.
GRFS's Altman-Z score of 1.17 is fine compared to the rest of the industry. GRFS outperforms 66.67% of its industry peers.
GRFS has a debt to FCF ratio of 46.43. This is a negative value and a sign of low solvency as GRFS would need 46.43 years to pay back of all of its debts.
GRFS's Debt to FCF ratio of 46.43 is amongst the best of the industry. GRFS outperforms 92.25% of its industry peers.
A Debt/Equity ratio of 1.65 is on the high side and indicates that GRFS has dependencies on debt financing.
Looking at the Debt to Equity ratio, with a value of 1.65, GRFS is doing worse than 80.90% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.65 | ||
| Debt/FCF | 46.43 | ||
| Altman-Z | 1.17 |
ROIC/WACC0.6
WACC7.22%
2.3 Liquidity
GRFS has a Current Ratio of 2.26. This indicates that GRFS is financially healthy and has no problem in meeting its short term obligations.
GRFS's Current ratio of 2.26 is on the low side compared to the rest of the industry. GRFS is outperformed by 73.69% of its industry peers.
GRFS has a Quick Ratio of 2.26. This is a bad value and indicates that GRFS is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.79, GRFS is not doing good in the industry: 90.27% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.26 | ||
| Quick Ratio | 0.79 |
3. Growth
3.1 Past
GRFS shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -71.52%.
Measured over the past years, GRFS shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -36.87% on average per year.
Looking at the last year, GRFS shows a quite strong growth in Revenue. The Revenue has grown by 8.71% in the last year.
GRFS shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 8.00% yearly.
EPS 1Y (TTM)-71.52%
EPS 3Y-54.06%
EPS 5Y-36.87%
EPS Q2Q%-13.31%
Revenue 1Y (TTM)8.71%
Revenue growth 3Y7.27%
Revenue growth 5Y8%
Sales Q2Q%12.24%
3.2 Future
GRFS is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 26.34% yearly.
The Revenue is expected to grow by 6.93% on average over the next years.
EPS Next Y38.57%
EPS Next 2Y43.78%
EPS Next 3Y36.8%
EPS Next 5Y26.34%
Revenue Next Year7.59%
Revenue Next 2Y7.29%
Revenue Next 3Y7.13%
Revenue Next 5Y6.93%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 33.45 indicates a quite expensive valuation of GRFS.
Based on the Price/Earnings ratio, GRFS is valued cheaper than 94.59% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 27.34. GRFS is valued slightly more expensive when compared to this.
Based on the Price/Forward Earnings ratio of 7.21, the valuation of GRFS can be described as very cheap.
Based on the Price/Forward Earnings ratio, GRFS is valued cheaper than 98.56% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.61, GRFS is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 33.45 | ||
| Fwd PE | 7.21 |
4.2 Price Multiples
GRFS's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. GRFS is cheaper than 97.84% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, GRFS is valued cheaper than 95.68% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 22.87 | ||
| EV/EBITDA | 9.68 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of GRFS may justify a higher PE ratio.
A more expensive valuation may be justified as GRFS's earnings are expected to grow with 36.80% in the coming years.
PEG (NY)0.87
PEG (5Y)N/A
EPS Next 2Y43.78%
EPS Next 3Y36.8%
5. Dividend
5.1 Amount
No dividends for GRFS!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
GRIFOLS SA-ADR
NASDAQ:GRFS (1/10/2025, 12:10:05 PM)
7.36
-0.24 (-3.16%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)
Earnings (Next)
Inst Owners35.14%
Inst Owner Change0%
Ins Owners6.01%
Ins Owner ChangeN/A
Market Cap5.00B
Analysts74.29
Price Target14 (90.22%)
Short Float %1.32%
Short Ratio3.46
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-0.13%
PT rev (3m)-13.86%
EPS NQ rev (1m)-8.41%
EPS NQ rev (3m)-8.41%
EPS NY rev (1m)-8.41%
EPS NY rev (3m)-11.34%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-2.96%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 33.45 | ||
| Fwd PE | 7.21 | ||
| P/S | 0.69 | ||
| P/FCF | 22.87 | ||
| P/OCF | 8.92 | ||
| P/B | 0.91 | ||
| P/tB | N/A | ||
| EV/EBITDA | 9.68 |
EPS(TTM)0.22
EY2.99%
EPS(NY)1.02
Fwd EY13.88%
FCF(TTM)0.32
FCFY4.37%
OCF(TTM)0.82
OCFY11.21%
SpS10.62
BVpS8.11
TBVpS-8.04
PEG (NY)0.87
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.71% | ||
| ROE | 2.69% | ||
| ROCE | 5.57% | ||
| ROIC | 4.34% | ||
| ROICexc | 4.54% | ||
| ROICexgc | 12.03% | ||
| OM | 14.26% | ||
| PM (TTM) | 2.05% | ||
| GM | 38.79% | ||
| FCFM | 3.03% |
ROA(3y)0.74%
ROA(5y)2.06%
ROE(3y)2.61%
ROE(5y)6.58%
ROIC(3y)2.86%
ROIC(5y)4.04%
ROICexc(3y)3.11%
ROICexc(5y)4.5%
ROICexgc(3y)6.99%
ROICexgc(5y)10.21%
ROCE(3y)3.67%
ROCE(5y)5.18%
ROICexcg growth 3Y-17.96%
ROICexcg growth 5Y-21.57%
ROICexc growth 3Y-18.29%
ROICexc growth 5Y-16.49%
OM growth 3Y-15.14%
OM growth 5Y-12.82%
PM growth 3Y-57.33%
PM growth 5Y-41.65%
GM growth 3Y-3.59%
GM growth 5Y-3.69%
F-Score6
Asset Turnover0.35
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.65 | ||
| Debt/FCF | 46.43 | ||
| Debt/EBITDA | 6.16 | ||
| Cap/Depr | 76.03% | ||
| Cap/Sales | 4.73% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 37.89% | ||
| Profit Quality | 147.43% | ||
| Current Ratio | 2.26 | ||
| Quick Ratio | 0.79 | ||
| Altman-Z | 1.17 |
F-Score6
WACC7.22%
ROIC/WACC0.6
Cap/Depr(3y)82.17%
Cap/Depr(5y)99.12%
Cap/Sales(3y)5.69%
Cap/Sales(5y)6.39%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-71.52%
EPS 3Y-54.06%
EPS 5Y-36.87%
EPS Q2Q%-13.31%
EPS Next Y38.57%
EPS Next 2Y43.78%
EPS Next 3Y36.8%
EPS Next 5Y26.34%
Revenue 1Y (TTM)8.71%
Revenue growth 3Y7.27%
Revenue growth 5Y8%
Sales Q2Q%12.24%
Revenue Next Year7.59%
Revenue Next 2Y7.29%
Revenue Next 3Y7.13%
Revenue Next 5Y6.93%
EBIT growth 1Y4.76%
EBIT growth 3Y-8.97%
EBIT growth 5Y-5.84%
EBIT Next Year93.72%
EBIT Next 3Y35.2%
EBIT Next 5Y25.79%
FCF growth 1Y77.45%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y2016.66%
OCF growth 3Y-42.76%
OCF growth 5Y-22.34%